Study Type
Observational
completed
The objective of the PRACTICE study was to examine the effects that clopidogrel has on bleeding and subsequent re-operation in patients who undergo coronary artery bypass (CABG) surgery and are receiving this medication.
Primary endpoints:
- Re-operation rates
- Incidence of serious blood transfusions (SBT) in patients hospitalized with ACS
- Related utilization outcomes and costs between patients receiving clopidogrel and those who do not, in patients hospitalized with ACS
NO. of Countries
1
NO. of Sites
10
NO. of Participants
500
Study Period
2009 - 2013
Sponsor
PHRI
Andre Lamy
Scientist
Andre Lamy
Scientist
Andre Lamy is a cardiac surgeon practicing at the Hamilton Health Sciences since 1996, and Professor in the Department of Surgery, McMaster University. He led the Canadian Institute of Health Research funded CORONARY trial, which evaluated off-pump CABG surgery versus on-pump CABG surgery in 4752 patients. The results were published in the New England Journal of Medicine in 2012 and 2013.
Jessica Vincent
Program Director
Jessica Vincent
Program Director
Jessica Vincent has more than 15 years’ experience in coordinating and managing large, international clinical trials. As Associate Program Manager, she oversees interventional trials, registries, and observational research studies in the areas of perioperative medicine, cardiac surgery, and digital health.
She holds an Honours Bachelor of Science Degree from Queens University, and a Master of Clinical Epidemiology Degree from the University of Newcastle.
